Drug Safety

The Good Old Drugs!
pp. 271-273(3)
Author: Edwards, I. Ralph

How do we Safely Treat Depression in Children, Adolescents and Young Adults?
pp. 275-282(8)
Author: Jureidini, Jon

Bias in Benefit-Risk Appraisal in Older Products: The Case of Buflomedil for Intermittent Claudication
pp. 283-291(9)
Authors: De Backer, Tine L.M.; Stichele, Robert H. Vander; Van Bortel, Luc M.

Managing Epilepsy in Women of Childbearing Age
pp. 293-307(15)
Author: Crawford, Pamela M.

Vaccines and Guillain-Barré Syndrome
pp. 309-323(15)
Authors: Haber, Penina; Sejvar, James; Mikaeloff, Yann; DeStefano, Frank

Paediatric Atypical Antipsychotic Monitoring Safety (PAMS) Study: Pilot Study in Children and Adolescents in Secondary- and Tertiary-Care Settings
pp. 325-333(9)
Authors: Rani, Fariz A.; Byrne, Patrick J.; Murray, Macey L.; Carter, Paul; Wong, Ian C.K.

Iatrogenic Effects of COX-2 Inhibitors in the US Population: Findings from the Medical Expenditure Panel Survey
pp. 335-343(9)
Authors: Vaithianathan, Rhema; Hockey, Peter M.; Moore, Thomas J.; Bates, David W.

Adverse Drug Reactions to Local Anaesthetics: A Review of the French Pharmacovigilance Database
pp. 345-356(12)
Authors: Fuzier, Régis; Lapeyre-Mestre, Maryse; Samii, Kamran; Montastruc, Jean-Louis

Spontaneous Reports and Pharmacogenetics: The Role of the Pharmacovigilance Centre
pp. 357-358(2)
Authors: >Eugène van Puijenbroek,; Conemans, Jean; >Kees van Grootheest,